Telomir Pharmaceuticals (TELO) Stock Chart & Stock Price History $3.91 -0.27 (-6.46%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$3.94 +0.03 (+0.90%) As of 02/21/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Telomir Pharmaceuticals Stock Price Performance 5 Day Performance-8.86%1 Month Performance-21.49%3 Month Performance-7.78%6 Month Performance-30.92%Year-To-Date Performance-5.10%1 Year Performance-56.12% Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address TELO Stock Chart for Saturday, February, 22, 2025 TELO Chart by TradingView Telomir Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$4.18$3.91-6.46%$4.34$3.90145,947 shs$116.37 million02/20/2025$4.21$4.18-0.71%$4.25$4.0960,610 shs$124.40 million02/19/2025$3.92$4.21+7.40%$4.22$3.75105,893 shs$125.29 million02/18/2025$4.29$3.92-8.62%$4.20$3.86335,022 shs$116.66 million02/17/2025$4.29$4.29$4.30$4.1755,484 shs$127.67 million02/14/2025$4.27$4.29+0.47%$4.30$4.1755,484 shs$127.67 million02/13/2025$4.25$4.27+0.47%$4.32$4.2251,507 shs$127.08 million02/12/2025$4.37$4.25-2.75%$4.48$4.16210,843 shs$126.49 million02/11/2025$4.47$4.37-2.24%$4.52$4.3578,720 shs$130.05 million02/10/2025$4.37$4.47+2.29%$4.65$4.3766,564 shs$133.03 million Get the Latest News and Ratings for TELO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$4.52$4.37-3.32%$4.65$4.32167,368 shs$129.40 million02/06/2025$4.65$4.52-2.80%$4.83$4.5069,598 shs$133.84 million02/05/2025$4.51$4.65+3.10%$4.66$4.5077,298 shs$137.69 million02/04/2025$4.17$4.51+8.15%$4.62$4.17128,303 shs$133.54 million02/03/2025$4.86$4.17-14.20%$4.98$4.14384,264 shs$123.47 million01/31/2025$4.52$4.86+7.52%$5.02$4.54125,157 shs$143.91 million01/30/2025$4.51$4.52+0.22%$4.65$4.5141,622 shs$133.84 million01/29/2025$4.64$4.51-2.80%$4.80$4.5092,074 shs$133.54 million01/28/2025$4.75$4.64-2.32%$4.88$4.56123,505 shs$137.39 million01/27/2025$5.03$4.75-5.57%$5.00$4.6753,759 shs$140.65 million01/24/2025$4.75$5.03+5.89%$5.08$4.6770,785 shs$148.94 million01/23/2025$4.98$4.75-4.62%$5.01$4.6753,674 shs$140.65 million01/22/2025$4.93$4.98+1.01%$5.15$4.8372,201 shs$147.46 million01/21/2025$4.69$4.93+5.12%$5.00$4.6263,197 shs$145.98 million Related Companies Xeris Biopharma Stock Price Chart Precigen Stock Price Chart Humacyte Stock Price Chart Tectonic Therapeutic Stock Price Chart Alpha Teknova Stock Price Chart Mineralys Therapeutics Stock Price Chart SNDL Stock Price Chart Entrada Therapeutics Stock Price Chart Kamada Stock Price Chart Cartesian Therapeutics Stock Price Chart Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TELO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
